Compare GRFS & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | RXO |
|---|---|---|
| Founded | 1940 | 2022 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.0B |
| IPO Year | 2008 | 2022 |
| Metric | GRFS | RXO |
|---|---|---|
| Price | $7.53 | $28.66 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 18 |
| Target Price | $10.87 | ★ $26.23 |
| AVG Volume (30 Days) | 445.0K | ★ 2.7M |
| Earning Date | 07-28-2022 | 11-05-2026 |
| Dividend Yield | ★ 1.14% | N/A |
| EPS Growth | N/A | ★ 72.81 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,742,000,000.00 |
| Revenue This Year | $1.73 | $19.26 |
| Revenue Next Year | $6.26 | $10.06 |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | N/A | ★ 26.20 |
| 52 Week Low | $6.96 | $10.43 |
| 52 Week High | $9.90 | $29.90 |
| Indicator | GRFS | RXO |
|---|---|---|
| Relative Strength Index (RSI) | 51.65 | 80.81 |
| Support Level | $7.44 | $25.28 |
| Resistance Level | $7.73 | $29.46 |
| Average True Range (ATR) | 0.12 | 1.01 |
| MACD | 0.02 | 1.03 |
| Stochastic Oscillator | 91.57 | 95.06 |
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.